Massachusetts Financial Services’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Massachusetts Financial Services's DNA Position: Q3 2026 in Review
Massachusetts Financial Services reduced its Ginkgo Bioworks (DNA) stake by 4.3% in Q3 2026, selling an estimated $16.6K and leaving 45,051 shares worth $578K. The position accounts for ﹤0.01% of the portfolio, ranked #926.
Massachusetts Financial Services first reported a position in DNA in Q3 2025 and has held it in 5 quarters since. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Massachusetts Financial Services held 45,051 shares of Ginkgo Bioworks worth $578K as of Q3 2026.
- Massachusetts Financial Services sold 2,039 Ginkgo Bioworks shares in Q3 2026, an estimated $16.6K.
- Ginkgo Bioworks made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q3 2026, its #926 holding.
- Massachusetts Financial Services first reported a position in Ginkgo Bioworks in Q3 2025 and has held it in 5 quarters since.
- 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.